Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Interoception in Adolescents With Restrictive Eating Disorders and Autism Spectrum Disorder (INT-REDS-ASD)

16 de novembro de 2026 atualizado por: Fondazione IRCCS San Gerardo dei Tintori

"Tuning Into My Body": A Study of Interoception in Adolescents With Restrictive Eating Disorders and Comorbid Autism Spectrum Disorder

The goal of this observational study is to describe interoception (the ability to sense signals from inside the body, such as heartbeat, hunger, and fullness) in three groups of adolescents aged 13 to 18: those with restrictive eating disorders (REDs), those with autism spectrum disorder (ASD), and those with both REDs and ASD.

The main questions it aims to answer are:

  • What is the level of interoceptive accuracy (how precisely participants perceive their own heartbeat), as measured by the Heartbeat Counting Task (HCT), in each of the three groups?
  • What is the level of interoceptive sensitivity (how participants self-report their awareness of body signals), as measured by the Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2), in each of the three groups?

In each group, researchers will also explore whether interoceptive accuracy and sensitivity are associated with:

  • socio-demographic and clinical characteristics (gender, age, body mass index, illness duration, and IQ)
  • psychological characteristics, including alexithymia (difficulty identifying and describing emotions), eating disorder symptoms and their severity, general psychological distress, and emotion dysregulation

Participants will:

  • Complete the Heartbeat Counting Task (HCT), in which they silently count their own heartbeats
  • Fill in the MAIA-2 questionnaire about body awareness, along with other questionnaires about eating behaviors, emotions, and general well-being

All information will be collected during the standard clinical assessment, with no extra visits or procedures.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Descrição detalhada

Restrictive eating disorders (REDs), including anorexia nervosa and avoidant/restrictive food intake disorder, and autism spectrum disorder (ASD) frequently co-occur, and their overlap is associated with more severe psychopathology. Interoception, the process by which the nervous system senses, interprets, and integrates signals from inside the body, has been found to be impaired in both conditions, but little is known about interoception in adolescents with REDs and comorbid ASD.

Following the multidimensional model proposed by Garfinkel et al. (2015), this multicenter prospective observational study will assess two dimensions of interoception: interoceptive accuracy (objective performance in detecting internal body signals) and interoceptive sensitivity (self-reported perception of body signals). Three clinical groups of adolescents will be described: REDs only, ASD only, and REDs with comorbid ASD.

No study-specific procedures are planned. During the standard psychodiagnostic assessment, participants complete a modified Heartbeat Counting Task (HCT) with a time estimation control task, the MAIA-2, and other self-report questionnaires (TAS-20, EDI-3, SCL-90-R, AQ, EQ, DERS-IT-SF), and undergo cognitive assessment (WISC-V). Socio-demographic and clinical data are also collected. Interoceptive accuracy and sensitivity will be described in each group with measures of location and variability and 95% confidence intervals, and their associations with socio-demographic, clinical, and psychological variables will be explored.

Tipo de estudo

Observacional

Inscrição (Estimado)

180

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

    • Bo
      • Bologna, Bo, Itália, 40138
        • IRCCS Istituto delle Scienze Neurologiche di Bologna
        • Contato:
    • MB
    • PD
      • Padova, PD, Itália, 35128
        • Azienda Ospedale-Università Padova
        • Contato:
    • PV
      • Pavia, PV, Itália, 27100
        • Fondazione IRCCS Mondino
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

13 anos a 18 anos (Filho, Adulto)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

Adolescents aged 13 to 18 years with a confirmed DSM-5-TR diagnosis of restrictive eating disorder (anorexia nervosa or avoidant/restrictive food intake disorder), autism spectrum disorder (level 1), or restrictive eating disorder with comorbid autism spectrum disorder (level 1), recruited during their standard psychodiagnostic assessment among patients under the care of four Italian child and adolescent neuropsychiatry centers: Fondazione IRCCS San Gerardo dei Tintori (Monza, coordinating center), IRCCS Istituto delle Scienze Neurologiche di Bologna, Azienda Ospedale-Università Padova, and Fondazione IRCCS Mondino (Pavia).

Descrição

Inclusion Criteria:

  • Confirmed diagnosis, according to DSM-5-TR criteria, of one of the following: restrictive eating disorder (anorexia nervosa or avoidant/restrictive food intake disorder); autism spectrum disorder, level 1; or restrictive eating disorder with comorbid autism spectrum disorder, level 1
  • Age between 13 and 18 years at diagnosis
  • Written informed consent freely given and obtained before the start of the study from the participant and/or parent or legal guardian

Exclusion Criteria:

  • Intellectual disability (IQ < 70)
  • Insufficient understanding of the Italian language
  • Past or current psychotic disorders

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Modelos de observação: COHORT
  • Perspectivas de Tempo: PROSPECTIVE

Coortes e Intervenções

Grupo / Coorte
Restrictive Eating Disorders (REDs)

Adolescents aged 13 to 18 years at diagnosis with a confirmed diagnosis of a restrictive eating disorder (anorexia nervosa or avoidant/restrictive food intake disorder) according to DSM-5-TR criteria, without autism spectrum disorder.

Autism Spectrum Disorder (ASD)

Adolescents aged 13 to 18 years at diagnosis with a confirmed diagnosis of autism spectrum disorder, level 1, according to DSM-5-TR criteria, without a restrictive eating disorder.

REDs With Comorbid ASD

Adolescents aged 13 to 18 years at diagnosis with a confirmed diagnosis of a restrictive eating disorder (anorexia nervosa or avoidant/restrictive food intake disorder) and comorbid autism spectrum disorder, level 1, according to DSM-5-TR criteria.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Interoceptive Accuracy Measured by the Heartbeat Counting Task (HCT)
Prazo: At enrollment, during the standard diagnostic assessment

Interoceptive accuracy assessed with a modified version of the Heartbeat Counting Task. Participants silently count their heartbeats, without taking their pulse, during four randomized time intervals while heart rate is recorded with a finger pulse oximeter. The accuracy score is calculated as the mean across intervals of [1 - |(recorded heartbeats - counted heartbeats) / recorded heartbeats|] × 100. Scores range from 0 to 100, with higher scores indicating greater interoceptive accuracy.

At enrollment, during the standard diagnostic assessment
Interoceptive Sensibility Measured by the Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2)
Prazo: At enrollment, during the standard diagnostic assessment

Self-reported interoceptive sensibility assessed with the MAIA-2, a 37-item questionnaire rated on a 6-point scale (0-5). Mean scores are calculated for each of the 8 subscales (Noticing, Not-Distracting, Not-Worrying, Attention Regulation, Emotional Awareness, Self-Regulation, Body Listening, Trusting) and range from 0 to 5. Higher scores indicate greater interoceptive sensibility.

At enrollment, during the standard diagnostic assessment

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Correlations Between Interoceptive Measures and Sociodemographic Variables
Prazo: At enrollment, during the standard diagnostic assessment

Correlations of HCT accuracy (score 0-100) and MAIA-2 subscale scores (0-5) with gender (number of participants per category) and age (years), collected from clinical records. Analyzed in each clinical group.

At enrollment, during the standard diagnostic assessment
Correlations Between Interoceptive Measures and Clinical Variables
Prazo: At enrollment, during the standard diagnostic assessment

Correlations of HCT accuracy (score 0-100) and MAIA-2 subscale scores (0-5) with body mass index (BMI, kg/m²), duration of illness (months), and Full Scale IQ measured by the WISC-V (standard score, mean 100, SD 15), collected from clinical records. Analyzed in each clinical group.

At enrollment, during the standard diagnostic assessment
Alexithymia Measured by the Toronto Alexithymia Scale (TAS-20)
Prazo: At enrollment, during the standard diagnostic assessment

Alexithymia assessed with the TAS-20, a 20-item self-report questionnaire rated on a 5-point Likert scale. Total score ranges from 20 to 100 (subscales: Difficulty Identifying Feelings, Difficulty Describing Feelings, Externally Oriented Thinking); higher scores indicate greater alexithymia. Scores will be analyzed for their correlations with HCT accuracy and MAIA-2 scores in each clinical group.

At enrollment, during the standard diagnostic assessment
Eating Disorder Symptom Severity Measured by the Eating Disorder Inventory-3 (EDI-3)
Prazo: At enrollment, during the standard diagnostic assessment

Eating disorder symptoms assessed with the EDI-3, a 91-item self-report questionnaire comprising 12 primary scales and 6 composite scales, including the Eating Disorder Risk Composite. Raw scores are converted to T-scores; higher scores indicate greater symptom severity. Scores will be analyzed for their correlations with HCT accuracy and MAIA-2 scores in each clinical group.

At enrollment, during the standard diagnostic assessment
General Psychopathology Measured by the Symptom Checklist-90-Revised (SCL-90-R)
Prazo: At enrollment, during the standard diagnostic assessment

General psychopathology assessed with the SCL-90-R, a 90-item self-report questionnaire rated from 0 to 4, covering 9 symptom dimensions. The Global Severity Index (GSI) ranges from 0 to 4; higher scores indicate greater psychological distress. Scores will be analyzed for their correlations with HCT accuracy and MAIA-2 scores in each clinical group.

At enrollment, during the standard diagnostic assessment
Emotion Dysregulation Measured by the Difficulties in Emotion Regulation Scale - Italian Short Form (DERS-IT-SF)
Prazo: At enrollment, during the standard diagnostic assessment

Emotion dysregulation assessed with the DERS-IT-SF, a self-report questionnaire rated on a 5-point Likert scale. Higher total and subscale scores indicate greater difficulties in emotion regulation. Scores will be analyzed for their correlations with HCT accuracy and MAIA-2 scores in each clinical group.

At enrollment, during the standard diagnostic assessment

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Cadeira de estudo: Renata Nacinovich, Fondazione IRCCS San Gerardo dei Tintori

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de novembro de 2026

Conclusão Primária (Estimado)

1 de novembro de 2027

Conclusão do estudo (Estimado)

1 de dezembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

6 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

16 de novembro de 2026

Primeira postagem (Real)

18 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • INT-REDS-ASD
  • 7306 (Outro identificador: Comitato Etico Territoriale Lombardia 3 (Territorial Ethics Committee Lombardy 3))

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Descrição do plano IPD

A decision on sharing individual participant data has not yet been made. Any future sharing of pseudonymized data would take place only in accordance with the informed consent, the EU General Data Protection Regulation (GDPR), and applicable Italian data protection law.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .